A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter

Nature Cell Biology

Volumn 5, Issue 8, 2003, Pages 754-761

  Brès, Vanessa ^a   Kiernan, Rosemary E ^a   Linares, Laetitia K ^b   Chable Bessia, Christine ^a   Plechakova, Olga ^c   Tréand, Céline ^d   Emiliani, Stephane ^d   Peloponese, Jean Marie ^e   Jeang, Kuan Teh ^e   Coux, Olivier ^c   Scheffner, Martin ^b   Benkirane, Monsef ^a  

^a INSTITUTE OF HUMAN GENETICS   (France)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Centre National de la Recherche Scientifique   (France)

^d INSTITUT COCHIN   (France)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; REGULATOR PROTEIN; TRANSACTIVATOR PROTEIN; UBIQUITIN;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENETIC CODE; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

CELL LINE; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; TRANS-ACTIVATION (GENETICS); UBIQUITIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0042195822     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1023     Document Type: Article

References (32)

1. Thomas, D. & Tyers, M. Transcriptional regulation: Kamikaze activators. Curr. Biol. 10, R341-R343 (2000).
2. Conaway, R. C., Brower, C. S. & Conaway, J. W. Emerging roles of ubiquitin in transcription regulation. Science 296, 1254-1258 (2002).
3. Muratani, M. & Tansey, W. P. How the ubiquitin-proteasome system controls transcription. Nature Rev. Mol. Cell Biol. 4, 192-201 (2003).
4. Salghetti, S. E., Caudy, A. A., Chenoweth, J. G. & Tansey, W. P. Regulation of transcriptional activation domain function by ubiquitin. Science 293, 1651-1653 (2001).
5. Kiernan, R. E. et al. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol. Cell Biol. 21, 7956-7970 (2001).
6. Winston, J. T. et al. The SCFβ-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro. Genes Dev. 13, 270-283 (1999).
7. Lassot, I. et al. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(βTrCP) ubiquitin ligase. Mol. Cell Biol. 21, 2192-2202 (2001).
8. Leveillard, T. & Wasylyk, B. The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter. J. Biol. Chem. 272, 30651-30661 (1997).
9. Daujat, S., Neel, H. & Piette, J. MDM2: life without p53. Trends Genet. 17, 459-464 (2001).
10. Gu, L., Findley, H. W. & Zhou, M. MDM2 induces NF-κB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood 99, 3367-3375 (2002).
11. Wei, P., Garber, M. E., Fang, S. M., Fischer, W. H. & Jones, K. A. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92, 451-462 (1998).
12. Haupt, Y., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997).
13. Legube, G. et al. Tip60 is targeted to proteasome-mediated degradation by Mdm2 and accumulates after UV irradiation. EMBO J. 21, 1704-1712 (2002).
14. Pickart, C. M. Ubiquitin in chains. Trends Biochem. Sci. 25, 544-548 (2000).
15. Li, C. J., Wang, C., Friedman, D. J. & Pardee, A. B. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 92, 5461-5464 (1995).
16. Bres, V. et al. Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J. 21, 6811-6819 (2002).
17. Huang, L. M., Joshi, A., Willey, R., Orenstein, J. & Jeang, K. T. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13, 2886-2896 (1994).
18. Ferdous, A., Gonzalez, F., Sun, L., Kodadek, T. & Johnston, S. A. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell 7, 981-991 (2001).
19. Gonzalez, F., Delahodde, A., Kodadek, T. & Johnston, S. A. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296, 548-550 (2002).
20. Nelbock, P., Dillon, P. J., Perkins, A. & Rosen, C. A. A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248, 1650-1653 (1990).
21. Shibuya, H. et al. New human gene encoding a positive modulator of HIV Tat-mediated transactivation. Nature 357, 700-702 (1992).
22. Ohana, B. et al. The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. Proc. Natl Acad. Sci. USA 90, 138-412 (1993).
23. DeMartino, G. N. et al. Identification, purification, and characterization of a PA700-dependent activator of the proteasome. J. Biol. Chem. 271, 3112-3118 (1996).
24. Glickman, M. H. et al. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94, 615-623. (1998).
25. Rubin, D. M. et al. Identification of the gal4 suppressor Sug1 as a subunit of the yeast 26S proteasome. Nature 379, 655-657 (1996).
26. Treier, M., Staszewski, L. M. & Bohmann, D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787-798 (1994).
27. Kiernan, R. E. et al. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18, 6106-6118 (1999).
28. Ward, C. L., Omura, S. & Kopito, R. R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127 (1995).
29. Johnson, E. S., Ma, P. C., Ota, I. M. & Varshavsky, A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270, 17442-17456 (1995).
30. Clavel, F. & Charneau, P. Fusion from without directed by human immunodeficiency virus particles. J. Virol. 68, 1179-1185 (1994).
31. Benkirane, M. et al. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol Chem. 273, 24898-24905 (1998).
32. Lisztwan, J. et al. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. EMBO J. 17, 368-383 (1998).